Pegylated interferon alfa-2a monotherapy for hemodialysis patients with acute hepatitis C

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Chen-Hua LiuJia-Horng Kao

Abstract

Hemodialysis patients are at risk of hepatitis C virus (HCV) infection. However, little is known about the efficacy and safety of pegylated interferon (IFN) therapy for hemodialysis patients with acute hepatitis C. From 2005 through 2008, 35 hemodialysis patients with acute hepatitis C who did not have spontaneous clearance of HCV by 16 weeks were treated with pegylated IFN alfa-2a at a dosage of 135 microg weekly for 24 weeks. In contrast, 7 patients with clearance of HCV by 16 weeks were under observation only. Thirty-six hemodialysis patients from 2002-2005 who had acute hepatitis C but did not receive treatment served as historical controls. The primary efficacy and safety end points were sustained virologic response (undetectable HCV RNA levels at 24 weeks after therapy) by intention-to-treat analysis and treatment-related withdrawal. The rate of sustained virologic response in the treatment group was significantly higher than the rate of spontaneous HCV clearance in the control group (88.6% vs 16.7%; P < .001). Two patients (5.7%) prematurely terminated treatment at 8 and 10 weeks because of constitutional symptoms, and both did not have sustained virologic response. All but one patient had rapid virologic response (undet...Continue Reading

Citations

Dec 14, 2011·Current Gastroenterology Reports·Mohammad A B Al-FreahMichael A Heneghan
Sep 8, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Hung-Bin TsaiKuan-Yu Hung
Jan 26, 2011·Journal of Gastroenterology and Hepatology·Chen-Hua Liu, Jia-Horng Kao
Mar 12, 2011·Clinical Journal of the American Society of Nephrology : CJASN·Chen-Hua LiuJia-Horng Kao
May 9, 2014·International Journal of Nanomedicine·Chen-Hua Liu, Jia-Horng Kao
Dec 15, 2010·Hepatitis Research and Treatment·Hugo WeclawiakLionel Rostaing
Oct 2, 2015·Néphrologie & thérapeutique·Anaïs Vallet-Pichard, Stanislas Pol
Jul 13, 2011·Liver International : Official Journal of the International Association for the Study of the Liver·Chrisoula PipiliEvangelos Cholongitas
Aug 6, 2014·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·S Baid-AgrawalM Muche
Jan 18, 2014·Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia·Hossein KhedmatShahram Agah
Jul 17, 2012·Journal of Hepatology·Behzad HajarizadehGregory J Dore
Dec 23, 2017·Expert Opinion on Drug Metabolism & Toxicology·Ashly Maughan, Onyema Ogbuagu
Oct 10, 2012·Journal of Viral Hepatitis·F FabriziP Martin
Jan 28, 2015·World Journal of Hepatology·Ahmad Najib AzmiRosmawati Mohamed
Jan 17, 2015·World Journal of Gastroenterology : WJG·Roberto J Carvalho-FilhoMaria Lucia G Ferraz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.